|
FULC Fulcrum Therapeutics Inc 1680581 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-26,179,000.00 |
| Balance Sheet |
|
Current Assets
|
$322,851,000.00 |
|
Assets
|
$323,952,000.00 |
|
Current Liabilities
|
$10,298,000.00 |
|
Liabilities
|
$13,255,000.00 |
|
Equity
|
$310,697,000.00 |
|
Shares Out
|
76285157.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-34,789,000.00 |
|
Investing Cash Flow
|
$-114,431,000.00 |
| Market Analysis |
Market Cap
|
$293,697,854.45 |
|
Price
|
$3.85 |
|
BVPS
|
4.07 |
|
PB
|
0.95 |
|
EPS
|
-0.34 |
|
FCF
|
$-34,905,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:46 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:37 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-24 |
-0.31 |
|
| Apr |
May |
Jun |
|
|
2026-04-27 |
-0.25 |
|
|
|
| Jul |
Aug |
Sep |
|
|
2025-07-29 |
-0.28 |
|
|
|
| Oct |
Nov |
Dec |
|
|
2025-10-29 |
-0.31 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view FULC documents filed with the SEC.
FULC Filings
Clear
